SMARCA2 and urinary bladder carcinoma: The expression of SMARCA2 is closely related to the expressions of pyruvate kinase M2 (PKM2) and protein kinase AMP‐activated alpha 1 catalytic subunit (PRKAA1) genes as well as metastasis, which suggests that metabolic alterations exist in bladder cancer.